Roquefort Therapeutics plc (LON:ROQ)
London · Delayed Price · Currency is GBP · Price in GBX 1.225
-0.125 (-9.26%)
Jan 22, 2026, 8:26 AM GMT
Roquefort Therapeutics Market Cap
Roquefort Therapeutics has a market cap or net worth of 2.21 million as of January 22, 2026. Its market cap has decreased by -55.39% in one year.
Market Cap
2.21M
Enterprise Value
2.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.23
Market Cap Chart
Since March 22, 2021, Roquefort Therapeutics's market cap has increased from 2.19M to 2.21M, an increase of 1.07%. That is a compound annual growth rate of 0.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 2.21M | 8.00% |
| Dec 31, 2025 | 2.05M | -62.77% |
| Dec 31, 2024 | 5.50M | -41.29% |
| Dec 29, 2023 | 9.36M | 9.43% |
| Dec 30, 2022 | 8.56M | 13.33% |
| Dec 31, 2021 | 7.55M | 245.20% |
| Mar 22, 2021 | 2.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genflow Biosciences | 9.62M |
| Futura Medical | 7.05M |
| OptiBiotix Health | 6.61M |
| Nuformix | 6.33M |
| Cizzle Biotechnology Holdings | 5.75M |
| CRISM Therapeutics | 5.30M |
| Theracryf | 4.51M |
| BSF Enterprise | 3.59M |